Skip to main content
Clinical Trials/ITMCTR2100004498
ITMCTR2100004498
Recruiting
Phase 1

Clinical and basic research on the diagnosis and treatment of cold-dampness syndrome in rheumatoid arthritis by TCM

Zhuhai Integrated Traditional Chinese and Western Medicine Hospital0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
Zhuhai Integrated Traditional Chinese and Western Medicine Hospital
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Zhuhai Integrated Traditional Chinese and Western Medicine Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Inclusion criteria for patients with wind\-like pass were: 18\-65 years old; According to the 2010 American College of Rheumatology (ACR)/European League Against Rheumatology (EULAR) classification criteria for wind\-like classification; The syndromes of Chinese medicine accord with the syndrome of cold\-dampness blockage and the syndrome of hot\-dampness blockage; Signed informed consent.
  • 2\. Inclusion criteria for ankylosing spondylitis: 18\-65 years old; Compliance with the New York Standards for Ankylosing Spondylitis Revised 1984; The syndromes of Chinese medicine accord with the syndrome of cold\-dampness blockage; Signed informed consent.
  • 3\. Inclusion criteria for osteoarthritis: 18\-65 years old; In accordance with the 1991 American College of Rheumatology (ACR) classification of osteoarthritis standards; The TCM syndromes accord with the syndrome of cold\-dampness blockage; Signed informed consent.

Exclusion Criteria

  • 1\. With other rheumatic diseases (such as SLE, Sjogren's syndrome, systemic sclerosis, dermatomyositis, etc.);
  • 2\. Extrarticular manifestations of severe patients (such as high fever, multiple rheumatoid nodules, interstitial pneumonia, etc.);
  • 3\. patients with cardiovascular, lung, liver, kidney, hematopoietic system and other serious diseases;
  • 4\. patients with severe infection, organ failure or malignant tumor;
  • 5\. pregnant or lactating women;
  • 6\. patients with a history of mental illness and cognitive dysfunction can not cooperate.

Outcomes

Primary Outcomes

Not specified

Similar Trials